This thread provides yet more evidence that there is a massive global market for an inexpensive, simple and accurate blood test, suitable for mass population screening for early stages of colorectal cancer. There is money to be made for whoever gets there first.
Colostat does seem to be the front runner! 13 years of research by our Aussie scientists at CSIRO, and now 4 years of extensive clinical trials and development before market entry, it's not something that was dreamt up last year.
- Forums
- ASX - By Stock
- CanSense-CRC test (breakthrough)
This thread provides yet more evidence that there is a massive...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
0.001(1.67%) |
Mkt cap ! $15.16M |
Open | High | Low | Value | Volume |
6.1¢ | 6.1¢ | 6.1¢ | $366 | 6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 192904 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 192904 | 0.060 |
3 | 70988 | 0.059 |
2 | 25941 | 0.058 |
1 | 54545 | 0.055 |
2 | 79995 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 80000 | 1 |
0.070 | 76753 | 3 |
0.071 | 150525 | 1 |
0.072 | 2245 | 1 |
0.075 | 9200 | 1 |
Last trade - 13.49pm 03/07/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online